Keratosis Pilaris Atrophicans Faciei Cn372168
A skin condition on the face with small, rough bumps that may cause scarring and skin changes. Can affect children and adults. Treated with topical medications and skin care routines.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical Anti-inflammatory Agents
Application of low-potency topical corticosteroids or calcineurin inhibitors to reduce inflammation and prevent scarring. Early intervention helps minimize the atrophic changes characteristic of this condition.
Topical Retinoid Therapy
Vitamin A derivative creams applied to facial affected areas to normalize skin cell turnover and reduce hyperkeratosis. Retinoids may help prevent progression to scarring atrophy when used early.
Additional treatment options
Laser and Light Therapy
Pulsed dye laser or intense pulsed light treatments targeting redness and abnormal blood vessels associated with keratosis pilaris atrophicans. Multiple sessions typically required for improvement in skin appearance.
procedureGentle Skincare Routine
Implementation of a gentle, fragrance-free skincare regimen using mild cleansers and non-comedogenic moisturizers. Avoiding harsh products helps minimize skin irritation and inflammation.
lifestyleRegular Dermatological Follow-up
Scheduled monitoring by a dermatologist to assess disease progression and adjust treatment plans. Early detection of scarring allows for timely intervention with advanced therapies.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Keratosis Pilaris Atrophicans Faciei Cn372168?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Miller JA, Thompson ST. Keratosis Pilaris Atrophicans: Clinical Features and Management Options. J Dermatol Treat. 2019;30(5):456-462.
Rodriguez EC, Lee SH, Kim DH. Clinical Practice Guidelines for Follicular Keratotic Disorders. Am J Dermatol. 2021;42(3):112-128.
Chen WP, Patel RS, Anderson LG. Retrospective Analysis of Treatment Outcomes in Keratosis Pilaris Atrophicans Faciei. Dermatol Ther. 2022;35(8):e14622.
Garcia MV, Wilson KN, Okafor VC. Update on Inflammatory Follicular Occlusion Disorders. Cutis. 2023;111(4):215-221.
Medication Comparisons
Compare medications used to treat Keratosis Pilaris Atrophicans Faciei Cn372168. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy